Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.45 |
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 3/20 | 0.32 |
| ▸ | CA2 | P00918 | 3/20 | 0.32 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.32 |
| ▸ | TPSAB1 | Q15661 | 3/20 | 0.31 |
| ▸ | TPSD1 | Q9BZJ3 | 3/20 | 0.31 |
| ▸ | TPSG1 | Q9NRR2 | 3/20 | 0.31 |
| ▸ | CA12 | O43570 | 2/20 | 0.30 |
| ▸ | CA3 | P07451 | 2/20 | 0.30 |
| ▸ | CA4 | P22748 | 2/20 | 0.30 |
| ▸ | CA6 | P23280 | 2/20 | 0.30 |
| ▸ | CA5A | P35218 | 2/20 | 0.30 |
| ▸ | CA7 | P43166 | 2/20 | 0.30 |
| ▸ | CA9 | Q16790 | 2/20 | 0.30 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.30 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.30 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.30 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20233658 | 0.98 | SIGMAR1 (0.48) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL26126847 | 0.98 | SIGMAR1 (0.48) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL15108551 | 0.93 | NPC1 (0.48) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL6318844 | 0.93 | NPC1 (0.48) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL29291655 | 0.91 | NPC1 (0.45) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL9011558 | 0.88 | NPC1 (0.56) | NPC1NAAACA1CA2CA12 | |
| SCHEMBL26288724 | 0.86 | — | — | |
| SCHEMBL9011682 | 0.85 | NPC1 (0.54) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL9011791 | 0.85 | NPC1 (0.54) | NPC1SIGMAR1NAAACA1CA2 | |
| SCHEMBL262805 | 0.85 | NPC1 (0.54) | NPC1SIGMAR1NAAACA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250215116-A1 | ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-07-03 | — | — | US | disclosed |
| US-20250109090-A1 | METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-04-03 | — | — | US | disclosed |
| EP-4530284-A1 | METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT | Koei Chemical Company, Limited (JP) | 2025-04-02 | — | — | EP | disclosed |
| CN-119707822-A | Method for producing onium salt and method for purifying onium salt | 广荣化学株式会社 | 2025-03-28 | — | — | CN | disclosed |
| EP-4501914-A1 | ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE | Koei Chemical Company, Limited (JP) | 2025-02-05 | — | — | EP | disclosed |
| US-20250034600-A1 | ONIUM SALT COMPOSITIONS, METHODS FOR PRODUCING CELLULOSE HYDROLYSATES, ALCOHOLS AND/OR ORGANIC ACIDS IN THE PRESENCE OF ONIUM SALT COMPOSITIONS | KOEI CHEMICAL COMPANY, LIMITED (JP) | 2025-01-30 | — | — | US | disclosed |
| EP-4497830-A1 | ONIUM SALT COMPOSITIONS, METHODS FOR PRODUCING CELLULOSE HYDROLYSATES, ALCOHOLS AND/OR ORGANIC ACIDS IN THE PRESENCE OF ONIUM SALT COMPOSITIONS | Koei Chemical Company, Limited (JP) | 2025-01-29 | — | — | EP | disclosed |
| CN-119372264-A | Onium salt composition, method for producing cellulose hydrolysate, and method for producing alcohol and/or organic acid | 广荣化学株式会社 | 2025-01-28 | — | — | CN | disclosed |
| CN-119156376-A | Onium salt, onium salt composition, liquid composition containing onium salt and polysaccharide, process for producing the same, and process for recovering polysaccharide | 广荣化学株式会社 | 2024-12-17 | — | — | CN | disclosed |
| WO-2023189817-A1 | ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE | 広栄化学株式会社 | 2023-10-05 | — | — | WO | disclosed |
| US-6114534-A | REACTING A KETONE DERIVATIVE OF CARBAMOYL SUBSTITUTED HETEROCYCLE WITH PHOSPHORANE, FOLLOWED BY ACIDIFICATION TO FORM AN ANTICOAGULANT | ELI LILLY AND COMPANY (US) | 2000-09-05 | — | — | US | disclosed |
| US-6075147-A | OMEGA-PHENYL-OMEGA-(3-PYRIDYL)-OMEGA-ALKENOIC ACID DERIVATIVES BEARING A CARBAMOYL SUBSTITUTED OXAZOLYL OR OXAZOLINYL GROUP ON THE PHENYL RING IS USEFUL FOR THROMBOXANE RECEPTOR ANTAGONSIM OR THROMBOXANE SYNTHASE INHIBITOR | ELI LILLY AND COMPANY (US) | 2000-06-13 | — | — | US | disclosed |
| US-6031095-A | Intermediates in the preparation of substituted alkenoic acids | ELI LILLY AND COMPANY (US) | 2000-02-29 | — | — | US | disclosed |
| US-5990308-A | Intermediates in the preparation of substituted alkenoic acids | ELI LILLY AND COMPANY (US) | 1999-11-23 | — | — | US | disclosed |
| US-5849922-A | Preparation of substituted alkenoic acids | ELI LILLY AND COMPANY (US) | 1998-12-15 | — | — | US | disclosed |
| US-5849766-A | Carbamoyl substituted heterocycles | ELI LILLY AND COMPANY (US) | 1998-12-15 | — | — | US | disclosed |
| EP-0816361-A2 | Preparation of substituted alkenoic acids | ELI LILLY AND COMPANY (US) | 1998-01-07 | — | — | EP | disclosed |
| EP-0811621-A2 | Carbamoyl substituted oxazoles as thromboxane receptor antagonists | ELI LILLY AND COMPANY (US) | 1997-12-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250109090-A1 | METHOD FOR PRODUCING ONIUM SALT AND METHOD FOR PURIFYING ONIUM SALT | NOTUM, CA7, CROCC | NPC1 1753/4885SIGMAR1 2919/4885NAAA 76/4885 |
| US-20250034600-A1 | ONIUM SALT COMPOSITIONS, METHODS FOR PRODUCING CELLULOSE HYDROLYSATES, ALCOHOLS AND/OR ORGANIC ACIDS IN THE PRESENCE OF ONIUM SALT COMPOSITIONS | ADH5, ADH1C, AMY1A | NPC1 3775/4885SIGMAR1 2083/4885NAAA 358/4885 |
| US-20250215116-A1 | ONIUM SALT, ONIUM SALT COMPOSITION, LIQUID COMPOSITION CONTAINING ONIUM SALT AND POLYSACCHARIDE AND PRODUCTION METHOD THEREOF, AND METHOD FOR RECOVERING POLYSACCHARIDE | ALG1, FUT5, NANS | NPC1 1545/4885SIGMAR1 2459/4885NAAA 1244/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.